share_log

Wedbush Reiterates Outperform on Edgewise Therapeutics, Maintains $26 Price Target

Moomoo 24/7 ·  Apr 16 10:19

Wedbush analyst Laura Chico reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $26 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment